Management of refractory cirrhotic ascites: challenges and solutions

about

Management of refractory cirrhotic ascites: challenges and solutions

Item

http://www.wikidata.org/entity/Q57407557

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Management of refractory cirrhotic ascites: challenges and solutions

@en

Management of refractory cirrhotic ascites: challenges and solutions

@nl

type

Item

label

Management of refractory cirrhotic ascites: challenges and solutions

@en

Management of refractory cirrhotic ascites: challenges and solutions

@nl

prefLabel

Management of refractory cirrhotic ascites: challenges and solutions

@en

Management of refractory cirrhotic ascites: challenges and solutions

@nl

P1476

Management of refractory cirrhotic ascites: challenges and solutions

@en

P2093

Hideto Kawaratani

http://www.w3.org/2001/XMLSchema#string

Hiroaki Takaya

http://www.w3.org/2001/XMLSchema#string

Hiroshi Fukui

http://www.w3.org/2001/XMLSchema#string

Hitoshi Yoshiji

http://www.w3.org/2001/XMLSchema#string

Kosuke Kaji

http://www.w3.org/2001/XMLSchema#string

P2860

TIPS versus paracentesis for cirrhotic patients with refractory ascites

Do vasopressin V2 receptor antagonists benefit cirrhotics with refractory ascites?

Treatment and management of ascites and hepatorenal syndrome: an update

Hyponatremia in cirrhosis: pathophysiology and management

Management of refractory ascites in cirrhosis: Are we out of date?

Rethinking the role of non-selective beta blockers in patients with cirrhosis and portal hypertension

Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis

Soluble TNF-alpha-receptors I are prognostic markers in TIPS-treated patients with cirrhosis and portal hypertension

Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data.

Effects of paracentesis on hemodynamic parameters and respiratory function in critically ill patients

P304

55-71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/HMER.S136578

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30013405

http://www.w3.org/2001/XMLSchema#string

P932

6039068

http://www.w3.org/2001/XMLSchema#string